AAOS Now, May 2012
-
Metal-on-Metal: 2012 Update
On Feb. 10, 2011, the U.S. Food and Drug Administration (FDA) posted a public health communication on metal-on-metal (MoM) hip implants. This was followed by a request, issued on May 9, 2011, to several orthopaedic device makers for postmarket surveillance studies. In particular, the agency expressed interest in information related to adverse events involving these devices that may be associated with increased levels of cobalt and chromium in the bloodstream.
-
Pre- and Postoperatively, Ice Could Be Nice
Jesse A. Shantz, MD, MBA, is looking for a win-win-win. Currently a research fellow with the Orthopaedic Trauma Institute at the University of California at San Francisco (UCSF), Dr. Shantz is examining cryotherapy as a means of improving clinical outcomes, patient satisfaction, and costs associated with surgical repair of upper tibia fractures. Dr.
-
AAOS Hosts Spring Orthopaedic Quality Institute
On March 15, 2012, the American Association of Orthopaedic Surgeons (AAOS) held its Spring Orthopaedic Quality Institute (OQI) in Washington, D.C. The goal of the meeting was to refine the mission and purpose of AAOS quality initiatives and to formulate a strategy for moving forward. Participants included John R. Tongue, MD, AAOS president; Joshua J. Jacobs, MD, first vice-president; Kevin J.
-
AAOS Technology Overviews Focused on MoM
The AAOS has two technology overviews (TOs) focused on metal-on-metal (MoM) hip implants. The first, on hip resurfacing (HR), was released in December 2009. The second, on MoM implants used in both HR and total hip arthroplasty (THA), was released in December 2011. Both are available on the AAOS website, at www.aaos.org/technologyoverviews TOs are not intended to convey any official position by the AAOS.
-
Submit Manuscripts for 2013 Kappa Delta Awards
The American Academy of Orthopaedic Surgeons (AAOS) is soliciting manuscripts for the 2013 Kappa Delta Awards and the Orthopaedic Research and Education Foundation (OREF) Clinical Research Award. Up to two $20,000 Kappa Delta awards—the Elizabeth Winston Lanier Award and the Ann Doner Vaughan Award, one $20,000 Kappa Delta Young Investigator award, and one $20,000 OREF Clinical Research Award will be bestowed, provided manuscripts of requisite quality are submitted.